Moneycontrol » News » Business » Business News

Aurobindo Pharma gets US nod for seizure drug

Published on Fri, Nov 06, 2009 at 15:44 |  Source : Reuters

Updated at Fri, Nov 06, 2009 at 17:03  

18284 Investors following Aurobindo Pharm. Share this News with them.
0
0
Share on Tumblr
Aurobindo Pharma gets US nod for seizure drug

ALSO READ

Aurobindo Pharm

BSE | NSE 13/02/12

Aurobindo Pharma Ltd said on Friday it secured final approval from the US Food and Drug Administration for Lamotrigine tablets, used in the treatment of partial and generalised seizures.

The drug is the generic equivalent of Lamictal CD tablets, a brand of GlaxoSmithkline, it said in a statement to the BSE.

  

PREVIOUS STORY

Accumulate Dishman Pharma; target of Rs 64: Dolat Capital

NEXT STORY

RIL's KG-D6 may see a further dip in output

More on Moneycontrol
Headlines
view all »
Worst is over, eyeing NIM at 3.80%: SBI Boss
07:11 PM
Worst is over, eyeing NIM at 3.80%: SBI Boss
This Valentine's day market may break your heart: Experts
04:24 PM
This Valentine's day market may break your heart: Experts
RBS sees rupee rally to 44 levels against dollar
04:01 PM
RBS sees rupee rally to 44 levels against dollar
Investors peer past gloom, eye Asian economic rebound
07:52 PM
Investors peer past gloom, eye Asian economic rebound
Video of the day
Mkt may stay put or move higher until Budget: JRG Sec
play
09:38 AM
Mkt may stay put or move higher until Budget: JRG Sec
- in MARKET OUTLOOK
Minor gains on D-street: Is it time to book profits?
Listen Now!
Slideshows

Trending News

Business News

Tags: Aurobindo Pharma Ltd, US Food and Drug Administration, Lamotrigine tablets, partial and generalised seizures, Lamictal CD tablets, GlaxoSmithkline, BSE
NASA turns off its last mainframe computer
Will RBI regulation prevent a gold loan bubble? "Will RBI regulation prevent a gold loan bubble?"

News

Gopal Jain Says On CNBC-TV18 4 Months Indicates Urgency; However Is A Short Time Span

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 13 2012, 17:40

Bullish on gold, but see price correction ahead: Ventura

- in Commodities

Feb 13 2012, 17:39

Index funds best choice for long-term investment: Roongta

- in Investing

Interviews

Feb 13 2012, 19:27 | Source: CNBC-TV18

'Diverse offerings in power helping to withstand headwinds'  

Feb 13 2012, 18:28 | Source: CNBC-TV18

SBI: Expect NPAs to improve; restructuring not red flag  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Explore Moneycontrol

STOCKS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
MUTUAL FUNDS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Unit Linked Insurance Plans (ULIPs) | | Budget: 2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | Union Budget | Budget 2012  | Economic Survey  | Railway Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide | History India  | Up Polls |  Latest News  | Suzlon Energy | Rafale | Sun Pharma | Iran | Oil and Natural Gas Corporation | BSE Sensex | Reliance Power | Bonus share | Steel Authority of India Limited | State Bank of India
Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.